Our mission is to provide the “gold-standard” collection of well-characterised models and services for drug discovery to help our clients reduce the attrition rate of candidate compounds in the clinic, before they enter the clinic.
Crown Bioscience, Inc. is a Preclinical CRO with expertise in the disease areas of Oncology and Metabolic Disease . We are known for the breadth and quality of our in vitro and in vivo models, as well as our ability to help clients quantify the real efficacy and pharmacological profile of their candidate before they move into the clinic. www.crownbio.com
Mitra Biotech is a global leader in advancing personalized cancer treatment and empowering drug development & discovery. Our phenotypic CANscript platform delivers powerful insight for our biopharma partners. Because CANscript conserves the native tumor microenvironment and delivers 1:1 clinical correlation… Read More
The Jackson Laboratory is a leading provider of cancer mouse models and in vivo oncology services and a National Cancer Institute-designated Cancer Center. Drawing on decades of research experience we provide capabilities around model selection, husbandry and customizable oncology studies to help clients and researchers evaluate novel anti-cancer therapies. Our diverse oncology study protocols range from traditional xenograft services to PDX cancer models and advanced humanized mouse models for immuno-oncology drug development. www.jax.org
Champions Oncology was founded by renowned specialists in the field of cancer diagnosis, treatment, and research. The Champions Oncology team is comprised of seasoned oncology professionals passionately dedicated to working to accelerate oncology drug development, improve treatment outcomes and extend lives. Champions Personalized TumorGrafts™ empower patients and physicians using an in vivo xenograft mouse avatar-based diagnostic model that has shown to be predictive of a patients’ clinical response. championsoncology.com
Envigo provides essential research services, models and products for biopharmaceutical, crop protection, and chemical companies as well as universities, governments, and other research organizations. Our business is founded on a dedication to customer service and the expertise and experience of our 3,800 people. With over 50 locations worldwide we are committed to helping customers realize the full potential of their research and products as we work together to build a healthier and safer world… Read More
Horizon Discovery combines long scientific heritage in translational research with GENESIS™, a precision gene-editing platform incorporating rAAV, CRISPR and ZFN technologies. Horizon supplies genetically-defined cell lines, gene-editing tools and services, custom cell line generation, molecular reference standards, and contract research services to approaching 1,000 academic, clinical and biopharmaceutical organizations.
MI Bioresearch (MI), a preclinical oncology service provider, offers in vitro services, oncology pharmacology, in vivo imaging, and focal radiation to support research programs. Our team explores the effects of your drugs and biologics using both human and syngeneic models and multi-modality imaging systems. MI provides you with decision-driving data to help advance your drug candidate toward the next cancer research breakthrough. One Focus. One Purpose. Oncology Research.
Pharmatest Services Ltd is a CRO offering preclinical efficacy services for the pharmaceutical industry. We offer bothin vitro and in vivo models in the fields of oncology and skeletal diseases. In oncology we have special expertise in clinically predictive orthotopic and metastasis models, and especially models of bone metastasis.
VisualSonics is the world’s leading developer of high-resolution, ultrasound-based, in vivo micro-imaging systems designed specifically for non-invasive preclinical research. The company’s enabling technology allows researchers at the world’s most prestigious pharmaceutical and biotechnology companies, hospitals and universities to conduct research in cardiovascular, cancer, and developmental biology areas. The technology supports applications that include genetic research, phenotypic studies and drug development.
Fuel3D are developers of BioVolume™, a subcutaneous tumor scanning and measurement system. Co-developed and deployed in oncology research by leading pharmaceutical company AstraZeneca to replace caliper measurement for analysis of subcutaneous tumors in xenograft models. BioVolume supports Animal Welfare and benefits 3R’s across Oncology In-vivo Research.
Stop by the stand for a demonstration of the technology.